Dear colleagues and friends,
After a rigorous search and selection process beginning in early 2019, Transplantation has a new clinical liver editorial team. ILTS thanks the outgoing editors, who have transformed our official journal since taking over in 2015, and welcomes their successors. The journal is on an upward trajectory, and the new team has the scientific and editorial expertise to reinforce this exciting trend.
This month’s newsletter also contains links to online nomination forms for a new ILTS council member and president-elect. Please take a minute to tell us who you think should represent and serve our society in the years to come.
Last but not least, ILTS has a number of annual travel awards, and scholarships for members of the liver transplant community – read more below and apply now!
|
|
Claus U. Niemann n
ILTS President
|
|
|
Help us bring the Liver Transplant community together:
Forward this newsletter to your colleagues!
|
|
ILTS 2020: Registration, abstract submission, and program are online
Register now for the 2020 Joint International Congress of ILTS, ELITA and LICAGE in Istanbul, May 6-9 and profit from the Early Bird discount! And remember: Abstract submission closes on December 2. You may find all the information about registration, abstracts, awards and the preliminary program on our website.
|
|
|
In the online abstract submission process, consider opting in for one of the 2020 Congress Awards:
- Rising Star Symposium
- Young Investigator Award
- Travel Award
|
|
We are constantly striving to make our conferences as valuable as possible for you. Please take a look at the summary and feedback for ILTS 2019 and get a glimpse at the new features we will offer you at ILTS 2020 in Istanbul.
|
|
|
ILTS 2020 Consensus Conference: Registration is still open
Specialists in machine perfusion technology and DCD liver transplantation will meet at the ILTS Consensus Conference (Venice Jan 31, 2020). This one-day event focuses on the latest trial results and innovations in this field.
|
|
|
By participating in the workshops, you will contribute to the Consensus Conference 2020 paper that will be published in Transplantation. Find out more about the program and register now!
|
|
Call for Nominations
Please send us your nominations by December 1:
1. The ILTS is looking for a new ILTS councilor, who should have a background of significant contributions to ILTS and to liver transplantation.
Nominate a Council Member
2. Nominate the next ILTS president-elect, who will serve a term of one year, following which he or she will succeed to the office of President. Only ILTS members can make nominations, and NOMINEES MUST BE CURRENT MEMBERS OF ILTS COUNCIL OR HAVE SERVED ON COUNCIL WITHIN THE PAST 5 YEARS.
Nominate a President-Elect
|
|
|
Become an ILTS Committee Member
The 13 ILTS committees promote education and communication in specialty areas and are instrumental in supporting the mission of our society. Would you like to participate? Most ILTS committees have membership positions available for the 2020 application cycle. You have until December 31 to apply!
|
|
|
2020 International Travel Scholar Award
The International Travel Scholar Award provides $10,000 to help trainees and younger faculty gain additional clinical and research experience in liver transplantation. Anyone with a fellowship or junior faculty position can apply. The deadline is December 29! APPLY NOW
|
|
ILTS Thanks Editors of Transplantation, a Journal Transformed
ILTS official journal Transplantation has a new clinical liver editorial team after an extensive search beginning in early 2019.
ILTS would like to sincerely thank the outgoing team, comprising Executive Editor Elizabeth A. Pomfret, MD, PhD (University of Colorado Hospital/Children's Hospital of Colorado, Aurora, CO, USA) and Deputy Editors Marina Berenguer, MD (Hospital University La Fe, Valencia, Spain), and Jean C. Emond, MD (Columbia University Medical Center, NY, USA), for their tireless efforts in rebuilding Transplantation.
Dr. Pomfret was the inaugural ILTS Executive Editor, taking the position in 2015 and leading the society through a challenging and highly successful transition to Transplantation. She has been unwavering in her commitment to the journal, and her leadership has been marked by rapidly increasing submissions of high quality manuscripts in the field of liver transplantation. She has been supported by equally dedicated and hard-working Deputy Editors, , and by an expert team of Associate Editors, the journal’s champions of peer review. Together with Editor-in-Chief Jeremy Chapman they have galvanized the journal and the landscape of international publication in our field .
ILTS expresses its deepest gratitude to all of them.
Introducing the new ILTS Liver Editorial Team:
Senior members of ILTS, in conjunction with the Editor-in-Chief, have spent several months seeking expressions of interest in the roles of Transplantation Executive and Deputy Editors. After a series of interviews and considerable thought, ILTS Council has endorsed the following team. We wish to thank all members involved in this successful search.
Executive Editor
Deputy Editor Clinical
- Francois Durand, MD
- Peter Friend, MD
Deputy Editor Basic
Associate Editors
- Albert Chan, MBBS, FRCS, FCSHK, FHKAM
- Manuel Rodriguez Davalos, MD
- James Findlay, MD
- Constantino Fondevila, MD, PhD
- Tom Gallagher, MS, MCh, FEBS, FRCSI
- Gabriel E. Gondolesi, MD, MAAC, FACS
- Keri Lunsford, MD, PhD
- Valeria Mas, PhD
- Eberhard Renner, MD, FRCP
- Erin Rubin, MD
- Faouzi Saliba, MD, PhD
- Gonzalo Sapisochin, MD
- Nazia Selzner, MD, PhD
- Mary Ann Simpson, MD
- Simone I Strasser, MBBS, MD, FRACP
- Yasuhiko Sugawar, MD, PhD
- Heidi Yeh, MD
- Gebhard Wagener, MD
Transplantation has been the official journal of ILTS since 2015. It is available free of charge to all ILTS members. The journal receives approximately 30 original liver submissions per month, selecting the best of these to publish alongside liver-related commentaries, state-of-the-art reviews, and ILTS guidelines, consensus statements and meeting reports. For more than 50 years it has been a reliable source of comprehensive and timely coverage of the most important advances in transplantation, and is now greatly enhanced by editorial and scientific contributions sponsored by ILTS. Its impact factor has risen from 3.69 to 4.734 since ILTS joined, now placing Transplantation 10th highest among all surgical journals.
|
|
TTS-ILTS Paired Transplant Centers Program
APPLY NOW for 2020 program entry
This unique educational initiative, co-sponsored by ILTS and The Transplantation Society, was launched in April 2019. It supports the sharing of expertise between an experienced center with good educational resources and a new, government-supported liver transplant unit in an emerging region. The program progresses in two-year stages to a total of six years, and up to three pairs may be selected to enter the program each year.
For more information and application details, visit tts-ilts.org . The deadline for applications for 2020 entry is 31 December 2019.
|
|
ILTS Special Interest Groups: Dedicated Discussion Forums
It's official, ILTS Special Interest Groups (SIGs) are up and running!
Dedicated SIG email addresses are now available to support clinical and educational discussions between SIG members. Members who have already joined an SIG can initiate discussions by contacting the dedicated SIG email address sent to them by ILTS on October 15th.. They must send from their own ILTS-registered email address to be recognized.
Members wishing to join an SIG can do this on their ILTS.org profile page, after which they will be sent an invitation. Please read the ILTS User Guide before posting.
|
|
Transplantation (FREE TO ILTS MEMBERS)
Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis
BACKGROUND: The true incidence and unique risk factors for recurrent and de novo nonalcoholic fatty liver (NAFLD) and nonalcoholic steatohepatitis (NASH)
post-liver transplant (LT) remain poorly characterized. We aimed to identify the
incidence and risk factors for recurrent and de novo NAFLD/NASH post-LT.
METHODS: MEDLINE via PubMed, Embase, Scopus, and CINAHL were searched for studies from 2000 to 2018. Read more
See commentary by Gökhan Kabaçam.
Transplantation (FREE TO ILTS MEMBERS)
The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients
BACKGROUND: Cardiovascular disease (CVD) is an important cause of morbidity and mortality after liver transplantation (LT). Serum adiponectin levels inversely correlate with CVD-related outcomes, but the relationship between hypoadiponectinemia and CVD after LT. Read more
See commentary by Ryan Chadha.
Transplantation (FREE TO ILTS MEMBERS)
A Multicenter Japanese Survey Assessing the Long-Term Outcomes of Liver Retransplantation using Living Donor Grafts
Liver transplantation is the most suitable treatment option available for end-stage liver disease. However, some patients require retransplantation, despite medical advances that have led to improved survival. Read more
See commentary by Yoon Young In.
Transplantation (FREE TO ILTS MEMBERS)
Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation
BACKGROUND: We examined the association between sarcopenia and post-transplant mortality in acutely ill inpatients with cirrhosis who underwent urgent liver transplantation.
METHODS: Included were inpatients at 4 centers who were urgently listed as nonstatus 1 and transplanted from 2005 to 2017 with an abdominal computed tomography scan <90 days before transplantation. Skeletal muscle index (SMI) = total skeletal muscle cross-sectional area at the L3 vertebral level, normalized to height. Read more
See commentary by Gökhan Kabaçam.
Journal of Hepatology
Donor outcomes in anonymous live liver donation
BACKGROUND & AIMS: Death rates on liver transplant waiting lists range from 5%-25%. Herein, we report a unique experience with 50 anonymous individuals who volunteered to address this gap by offering to donate part of their liver to a recipient with whom they had no biological connection or prior relationship, so called anonymous live liver donation (A-LLD).
METHODS: Candidates were screened to confirm excellent physical, mental, social, and financial health. Read more
See commentary by Gökhan Kabaçam.
Liver Transplantation
Impact of Temporary Portocaval Shunting and Initial Arterial Reperfusion in Orthotopic Liver Transplantation
The aim of this study was to evaluate outcome for the 4 possible combinations (temporary portocaval shunt with initial arterial reperfusion [A+S+], temporary portocaval shunt with initial portal reperfusion, no temporary portocaval shunt with initial arterial reperfusion, and no temporary portocaval shunt with initial portal reperfusion) in a center-based cohort study, including liver transplantations (LTs) from both donation after brain death and donation after circulatory death (DCD) donors. Read more
See commentary by Yoon Young In.
Transplantation Proceedings
Comparison Between Swan-Ganz Catheter and Minimally Invasive Hemodynamic Monitoring During Liver Transplantation: Report of a Monocentric Case Series
INTRODUCTION: The aim of the present investigation was to retrospectively evaluate the utilization of Swan-Ganz catheter during orthotopic liver transplantation as opposed to FloTrac/Vigileo in selected cases, comparing a number of clinical outcomes across. Read more
See commentary by Ryan Chadha.
American Journal of Transplantation
Pediatric living donor liver transplantation with large‐for‐size left lateral segment grafts
Usage of "large-for-size" left lateral segment (LLS) liver grafts in children with high graft to recipient weight ratio (GRWR) is controversial due to concerns about increased recipient complications. During the study period, 77 pediatric living donor liver transplantations (LDLTs) with LLS grafts were performed. We compared recipients with GRWR ≥2.5% (GR-High = 50) vs GRWR <2.5% (GR-Low = 27). Read more
See commentary by Yoon Young In.
BMC Nephrology
Early detection of acute kidney injury in the perioperative period of liver transplant with neutrophil gelatinase-associated lipocalin
Background: Acute kidney injury (AKI) is a common complication in patients undergoing liver transplant (LT) and is associated with high morbidity and mortality. We aim to evaluate the pattern of urine and plasma neutrophil gelatinase-associated lipocalin (NGAL) elevation. Read more
See commentary by Ryan Chadha.
|
|
Last Month
1. Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival. (link)
2. Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients During Their Evaluations. (link)
3. Older Donor Age Is a Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small-for-Size Grafts. (link)
|
|
2019
1. Recipient age and mortality after liver transplantation: A population-based cohort study (link)
2. Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy (link)
3. ILTS consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation (link)
|
|
|
|
